Vise Technologies Inc. Takes $261,000 Position in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX)

Vise Technologies Inc. acquired a new stake in shares of Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDXGet Rating) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 13,976 shares of the company’s stock, valued at approximately $261,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Principal Financial Group Inc. raised its position in shares of Ortho Clinical Diagnostics by 6.8% during the 1st quarter. Principal Financial Group Inc. now owns 21,871 shares of the company’s stock valued at $408,000 after purchasing an additional 1,390 shares during the period. Teacher Retirement System of Texas grew its stake in Ortho Clinical Diagnostics by 6.8% during the first quarter. Teacher Retirement System of Texas now owns 24,254 shares of the company’s stock valued at $453,000 after acquiring an additional 1,547 shares in the last quarter. PDT Partners LLC grew its stake in Ortho Clinical Diagnostics by 10.5% during the fourth quarter. PDT Partners LLC now owns 18,734 shares of the company’s stock valued at $401,000 after acquiring an additional 1,776 shares in the last quarter. Sei Investments Co. grew its stake in Ortho Clinical Diagnostics by 25.4% during the first quarter. Sei Investments Co. now owns 12,651 shares of the company’s stock valued at $249,000 after acquiring an additional 2,566 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. grew its stake in Ortho Clinical Diagnostics by 29.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 14,425 shares of the company’s stock valued at $269,000 after acquiring an additional 3,260 shares in the last quarter.

Ortho Clinical Diagnostics Stock Performance

OCDX opened at $17.63 on Friday. The stock has a market capitalization of $3.92 billion, a price-to-earnings ratio of -1,761.24, a PEG ratio of 1.66 and a beta of 1.32. The company has a fifty day moving average of $17.63 and a 200 day moving average of $17.80. Ortho Clinical Diagnostics Holdings plc has a fifty-two week low of $16.04 and a fifty-two week high of $22.99. The company has a debt-to-equity ratio of 4.91, a quick ratio of 1.29 and a current ratio of 1.89.

About Ortho Clinical Diagnostics

(Get Rating)

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results.

Further Reading

Institutional Ownership by Quarter for Ortho Clinical Diagnostics (NASDAQ:OCDX)

Receive News & Ratings for Ortho Clinical Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Clinical Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.